Density functional theory and molecular dynamics simulation-based bioprospection of Agathosma betulina essential oil metabolites against protein tyrosine phosphatase 1B for interventive antidiabetic therapy
Type II diabetes mellitus (T2DM) is characterized by elevated blood glucose due to impaired insulin secretion/sensitivity. While conventional antihyperglycemic medications like biguanides, sulfonylureas, and other agents are commonly used, their long-term use can have side effects, prompting researc...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S240584402500619X |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832087571975372800 |
---|---|
author | Oluwaseye Adedirin Rukayat A. Abdulsalam Khadeejah O. Nasir-Naeem Ayenitaju A. Oke Akolade O. Jubril Saheed Sabiu |
author_facet | Oluwaseye Adedirin Rukayat A. Abdulsalam Khadeejah O. Nasir-Naeem Ayenitaju A. Oke Akolade O. Jubril Saheed Sabiu |
author_sort | Oluwaseye Adedirin |
collection | DOAJ |
description | Type II diabetes mellitus (T2DM) is characterized by elevated blood glucose due to impaired insulin secretion/sensitivity. While conventional antihyperglycemic medications like biguanides, sulfonylureas, and other agents are commonly used, their long-term use can have side effects, prompting research into natural alternatives. This study bioprospects the antidiabetic potential of metabolites in Agathosma betulina (Buchu) essential oil through computational analysis of their ability to inhibit protein tyrosine phosphatase 1B (PTP1B), a therapeutic diabetes target. Molecular dynamic simulation, supported by DFT analysis, revealed that compounds linalylanthranilate (−20.18 kcal/mol) and γ-diosphenol (−16.49 kcal/mol) found in the oil exhibited stronger PTP1B inhibition than ursolic acid (−15.98 kcal/mol). The compounds showed favorable drug-like properties complying with Lipinski's rules. This study provides the first evidence that these Buchu oil compounds could potentially serve as PTP1B inhibitors to enhance insulin receptor sensitivity, showing promise for T2DM treatment. Further validation through safety and clinical studies is recommended. |
format | Article |
id | doaj-art-b13364e70f644e6e9e65e695944d2811 |
institution | Kabale University |
issn | 2405-8440 |
language | English |
publishDate | 2025-02-01 |
publisher | Elsevier |
record_format | Article |
series | Heliyon |
spelling | doaj-art-b13364e70f644e6e9e65e695944d28112025-02-06T05:12:35ZengElsevierHeliyon2405-84402025-02-01113e42239Density functional theory and molecular dynamics simulation-based bioprospection of Agathosma betulina essential oil metabolites against protein tyrosine phosphatase 1B for interventive antidiabetic therapyOluwaseye Adedirin0Rukayat A. Abdulsalam1Khadeejah O. Nasir-Naeem2Ayenitaju A. Oke3Akolade O. Jubril4Saheed Sabiu5Department of Biotechnology and Food Science, Faculty of Applied Sciences, Durban University of Technology, PO Box 1334, Durban, 4000, South Africa; Corresponding author.Department of Biotechnology and Food Science, Faculty of Applied Sciences, Durban University of Technology, PO Box 1334, Durban, 4000, South AfricaBiotechnology Advanced Research Centre, Sheda Science and Technology Complex, PO Box 186, Garki, Abuja, NigeriaBiotechnology Advanced Research Centre, Sheda Science and Technology Complex, PO Box 186, Garki, Abuja, NigeriaBiotechnology Advanced Research Centre, Sheda Science and Technology Complex, PO Box 186, Garki, Abuja, NigeriaDepartment of Biotechnology and Food Science, Faculty of Applied Sciences, Durban University of Technology, PO Box 1334, Durban, 4000, South AfricaType II diabetes mellitus (T2DM) is characterized by elevated blood glucose due to impaired insulin secretion/sensitivity. While conventional antihyperglycemic medications like biguanides, sulfonylureas, and other agents are commonly used, their long-term use can have side effects, prompting research into natural alternatives. This study bioprospects the antidiabetic potential of metabolites in Agathosma betulina (Buchu) essential oil through computational analysis of their ability to inhibit protein tyrosine phosphatase 1B (PTP1B), a therapeutic diabetes target. Molecular dynamic simulation, supported by DFT analysis, revealed that compounds linalylanthranilate (−20.18 kcal/mol) and γ-diosphenol (−16.49 kcal/mol) found in the oil exhibited stronger PTP1B inhibition than ursolic acid (−15.98 kcal/mol). The compounds showed favorable drug-like properties complying with Lipinski's rules. This study provides the first evidence that these Buchu oil compounds could potentially serve as PTP1B inhibitors to enhance insulin receptor sensitivity, showing promise for T2DM treatment. Further validation through safety and clinical studies is recommended.http://www.sciencedirect.com/science/article/pii/S240584402500619XDiabetesBuchuEssential oilPTP1BComputational screening |
spellingShingle | Oluwaseye Adedirin Rukayat A. Abdulsalam Khadeejah O. Nasir-Naeem Ayenitaju A. Oke Akolade O. Jubril Saheed Sabiu Density functional theory and molecular dynamics simulation-based bioprospection of Agathosma betulina essential oil metabolites against protein tyrosine phosphatase 1B for interventive antidiabetic therapy Heliyon Diabetes Buchu Essential oil PTP1B Computational screening |
title | Density functional theory and molecular dynamics simulation-based bioprospection of Agathosma betulina essential oil metabolites against protein tyrosine phosphatase 1B for interventive antidiabetic therapy |
title_full | Density functional theory and molecular dynamics simulation-based bioprospection of Agathosma betulina essential oil metabolites against protein tyrosine phosphatase 1B for interventive antidiabetic therapy |
title_fullStr | Density functional theory and molecular dynamics simulation-based bioprospection of Agathosma betulina essential oil metabolites against protein tyrosine phosphatase 1B for interventive antidiabetic therapy |
title_full_unstemmed | Density functional theory and molecular dynamics simulation-based bioprospection of Agathosma betulina essential oil metabolites against protein tyrosine phosphatase 1B for interventive antidiabetic therapy |
title_short | Density functional theory and molecular dynamics simulation-based bioprospection of Agathosma betulina essential oil metabolites against protein tyrosine phosphatase 1B for interventive antidiabetic therapy |
title_sort | density functional theory and molecular dynamics simulation based bioprospection of agathosma betulina essential oil metabolites against protein tyrosine phosphatase 1b for interventive antidiabetic therapy |
topic | Diabetes Buchu Essential oil PTP1B Computational screening |
url | http://www.sciencedirect.com/science/article/pii/S240584402500619X |
work_keys_str_mv | AT oluwaseyeadedirin densityfunctionaltheoryandmoleculardynamicssimulationbasedbioprospectionofagathosmabetulinaessentialoilmetabolitesagainstproteintyrosinephosphatase1bforinterventiveantidiabetictherapy AT rukayataabdulsalam densityfunctionaltheoryandmoleculardynamicssimulationbasedbioprospectionofagathosmabetulinaessentialoilmetabolitesagainstproteintyrosinephosphatase1bforinterventiveantidiabetictherapy AT khadeejahonasirnaeem densityfunctionaltheoryandmoleculardynamicssimulationbasedbioprospectionofagathosmabetulinaessentialoilmetabolitesagainstproteintyrosinephosphatase1bforinterventiveantidiabetictherapy AT ayenitajuaoke densityfunctionaltheoryandmoleculardynamicssimulationbasedbioprospectionofagathosmabetulinaessentialoilmetabolitesagainstproteintyrosinephosphatase1bforinterventiveantidiabetictherapy AT akoladeojubril densityfunctionaltheoryandmoleculardynamicssimulationbasedbioprospectionofagathosmabetulinaessentialoilmetabolitesagainstproteintyrosinephosphatase1bforinterventiveantidiabetictherapy AT saheedsabiu densityfunctionaltheoryandmoleculardynamicssimulationbasedbioprospectionofagathosmabetulinaessentialoilmetabolitesagainstproteintyrosinephosphatase1bforinterventiveantidiabetictherapy |